Share this article
Share this article
ORLANDO, Fla., May 4, 2021 /PRNewswire/ Cabenuva (cabotegravir/rilpivrine), the first and only once-monthly complete injectable treatment is available through AllianceRx Walgreens Prime for adults living with human immunodeficiency virus type 1 (HIV-1). Manufactured for ViiV Healthcare by GlaxoSmithKline, Cabenuva provides an alternative to patients who relied on a daily oral treatment regimen.
HIV is a virus that attacks the body s immune system. If not treated, it can lead to acquired immunodeficiency syndrome (AIDS).
1 HIV-1 is the predominant type of HIV worldwide, making up 95 percent of all HIV cases worldwide.
2 Cabenuva a complete regimen for the treatment of HIV-1 infection in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
AllianceRx Walgreens Prime, Highmark launch Social Determinants of Health Pilot
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Highmark, AllianceRx Walgreens Prime in social determinants of health pilot
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.